Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

REVEALED: 4 - The Real Truth

Recession odds are rising due to the onslaught of aggressive rate hikes by the Fed. Healthcare is conventionally considered a defensive sector. Hence, we think Johnson & Johnson (JNJ), AbbVie (ABBV), and Bristol-Myers Squibb (BMY) might be solid buys now. Read on….

StockNews.com

Try These 3 Stocks Ideas for a Golden Retirement

The U.S. market came back in July and early August owing to a robust job market, strong corporate earnings, and a slight decline in inflation. However, the Fed’s hawkish stance to hike the interest rates aggressively until inflation comes down to the target level is expected to keep the market…

StockNews.com

2 Pharma Stocks That'll Make You Rich in the Long Term

Substantial investments in R&D, an aging population, and growing demand for advanced drugs to treat chronic diseases should drive the pharmaceutical industry’s growth. Therefore, investing in fundamentally strong and dividend-paying pharma stocks Johnson & Johnson (JNJ) and Bristol-Myers Squibb (BMY) could help dodge the current market volatility and generate substantial…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

5 Income Stocks to Turn to When Times Are Tough

The S&P 500 is coming off its four-week win streak amid signals of cooling price increases. However, inflation is still running hot near a 40-year high, which might induce the Fed to continue its policy rate hikes. We think income stocks AbbVie (ABBV), Amgen (AMGN), Pfizer (PFE), Bristol-Myers Squibb (BMY),…

StockNews.com

5 Value Stocks to Buy Ahead of the Fall Season

The stock market has witnessed a rough ride amid macroeconomic headwinds this year. Despite the GDP decline for two consecutive quarters, economists believe the economy is far from recession. Here are five fundamentally solid value stocks AstroNova (ALOT), Bristol-Myers Squibb (BMY), Bluegreen Vacations (BVH), GSK (GSK), and Honda Motor (HMC),…

StockNews.com

3 High-Yield Dividend Stocks to Help You Beat Stagflation

With the Fed committed to its rate hikes to bring down inflation, employment staggering, and prices refusing to come down, stagflation might be around the corner. We believe these high-yield dividend stocks Natural Resource(NRP), Kronos Worldwide(KRO), and Bristol-Myers Squibb(BMY) might help one beat the stagflation. Read more….

StockNews.com

Is Biotech Ready for Another Bull Run? 3 Stocks to Get in Ahead of the Crowd

The biotech industry flourished during the height of the COVID-19 pandemic and reported record revenues and earnings last year. Despite the market slowdown, the sector is poised for another bull run, given the continued global fight against COVID-19 and the increasing demand with an aging population. Popular biotech stocks Pfizer…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

3 Cheap Large-Cap Stocks Still Beating the Market

With job growth remaining strong in June, the Fed is expected to raise interest rates aggressively. Therefore, the stock market may witness further downside. Amid this backdrop, it could be wise to invest in large-cap stocks Bristol-Myers Squibb (BMY), Bayer (BAYRY), and Mitsubishi Heavy Industries (MHVYF), which have shown resilience…

StockNews.com

5 Buy-Rated Healthcare Stocks Trading at a Discount

Inelastic demand, growing investments, and impressive breakthroughs should help the healthcare sector survive the potential recession. This is why we believe quality healthcare stocks Assertio (ASRT), Bayer (BAYRY), Bristol-Myers Squibb (BMY), Catalyst Pharmaceuticals (CPRX), and Ipsen (IPSEY), which are currently trading at discounts to their peers, could be solid investments…

StockNews.com

Scoop up These 5 Dividend Stocks on Sale

The Federal Reserve’s aggressive interest hikes have fostered recession fears and significant volatility in the stock market. So, investors can consider adding quality dividend stocks Embotelladora Andina (AKO.B), Bristol-Myers Squibb (BMY), Bayer Aktiengesellschaft (BAYRY), A.P. Møller - Mærsk A/S (AMKBY), and Honda Motor (HMC) to their portfolios to ensure a…

StockNews.com

3 Drug Manufacturers to Buy on the Pullback

The global pharmaceutical industry is expected to thrive with the lingering impact of COVID-19 and the evolving healthcare landscape. Given the industry’s solid prospects, the pullbacks in drug manufacturing stocks Merck & Co (MRK), Bristol-Myers Squibb (BMY), and Bayer Aktiengesellschaft (BAYRY) amid the broader market correction preset solid buying opportunity.…

StockNews.com

3 Red-Hot Healthcare Stocks Ignoring the Market's Downtrend

Despite bearish market sentiment, the healthcare industry has outperformed the broader market thanks to its defensive nature. Given overwhelming demand and the need for global healthcare development, we think the stocks of quality healthcare companies Cigna (CI), Organon (OGN), and Bristol-Myers Squibb (BMY) could be solid bets now. These stocks…

StockNews.com

3 Pharmaceutical Stocks That Look Like Huge Bargains

Increasing investments in R&D and rising expenditure on healthcare are expected to bolster the pharmaceutical sector's growth. Therefore, we think the stocks of fundamentally sound pharmaceutical companies Bristol-Myers Squibb (BMY), Bayer Aktiengesellschaft (BAYRY), and Catalyst Pharmaceuticals, Inc. (CPRX), which are currently trading at huge discounts to their peers, could be…

StockNews.com

How Does the Pharmaceutical Industry Perform During Recessions?

The Fed’s aggressive interest rate hikes and high energy prices will likely fuel recessionary conditions. Moreover, the unexpected decline in GDP in the first quarter indicates a possible economic contraction. Amid such possibilities, the pharmaceutical industry could attract investors’ attention because of the inelastic demand for its products. Today, I…

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

4 Incredibly Cheap Large-Cap Stocks to Buy Now

The stock market has been faced with significant volatility on concerns over surging inflation, the Fed’s anticipated interest rate hikes, and continuing geopolitical instability. However, the market selloffs have created an attractive opportunity to buy quality large-cap stocks at low prices. We believe fundamentally sound large-cap stocks Bristol (BMY), Micron…

Benzinga

Analyzing Bristol-myers Squibb Company's Short Interest

Bristol-myers Squibb Company's (NYSE:BMY) short percent of float has fallen 15.03% since its last report. The company recently reported that it has 53.73 million shares sold short, which is 2.43% of all regular shares that are available for trading.

Benzinga

Analyzing Bristol-myers Squibb Company's Short Interest

Bristol-myers Squibb Company's (NYSE:BMY) short percent of float has fallen 10.9% since its last report. The company recently reported that it has 63.20 million shares sold short, which is 2.86% of all regular shares that are available for trading.

StockNews.com

3 Top-Rated Stocks for Value Investors to Consider

The recent stock market correction has created a few attractive opportunities for investors because many stocks are now trading at reasonable valuations. Thus, it could be wise now to invest in fundamentally solid stocks Bristol-Myers (BMY), McKesson (MCK), and AGCO (AGCO). These names are currently trading at discounts compared to…

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Attention Biotech Investors: Mark Your Calendar For April PDUFA Dates

Biopharma stocks are sensitive to a key binary event called the PDUFA date, the date by which the Food and Drug Administration is required to give its verdict on a regulatory application filed with it.

StockNews.com

3 Red-Hot Large-Cap Stocks Outpacing the S&P 500

Large-cap stocks are generally known to provide better safety to investors during periods of volatility. Therefore, we think Bristol-Myers Squibb (BMY), Vertex (VRTX), and Molina Healthcare (MOH), which have been outpacing the S&P 500, might be good investments now.

1 2 3 4

People

Dipanjan BanchurSince

722 stories

Mangeet Kaur BounsMangeet

595 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.